Whitehawk Therapeutics, Inc. (WHWK)

Whitehawk Therapeutics Revenue

Whitehawk Therapeutics had revenue of $21.60M in the twelve months ending June 30, 2025, down -9.33% year-over-year. In the year 2024, Whitehawk Therapeutics had annual revenue of $25.98M with 6.69% growth.

• Revenue (ttm): $21.60M
• Revenue Growth: -9.33%
• P/S Ratio: 3.25
• Revenue / Employee: $539,900
• Employees: 40
• Market Cap: 79.14M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	25.98M	1.63M	6.69%
Dec 31, 2023	24.35M	9.14M	60.06%
Dec 31, 2022	15.22M	14.10M	1,258.57%
Dec 31, 2021	1.12M	-13.46M	-92.32%
Dec 31, 2020	14.58M	13.83M	1,846.60%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.